TW 004Alternative Names: TW004
Latest Information Update: 05 Jan 2016
At a glance
- Originator Treeway
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Amyotrophic lateral sclerosis
Most Recent Events
- 05 Jan 2016 Early research in Amyotrophic lateral sclerosis in Netherlands (unspecified route) before January 2016